Ozempic (Semaglutide)

What is Ozempic?

Ozempic for weight loss has been studied in clinical trials. After 30 weeks patients on Ozempic 0.5mg had lost 2.6 kg more than the placebo group, and patients on Ozempic 1mg lost 3.5 kg more than the placebo group. Ozempic is currently not an FDA-approved weight loss medicine.

Ozempic (semaglutide) is from a class of medicines called a glucagon-like peptide-1 (GLP-1) agonists (incretin mimetics) that works by binding to GLP-1 receptors, which results in lower blood sugar levels and A1C levels and may also reduce your appetite to help weight loss.

Ozempic is a once-weekly injection that should be used together with diet and exercise. Ozempic should not be used for type 1 diabetes mellitus.

Ozempic is used for type 2 diabetes to improve blood sugar levels in adults and also to lower the risk of major cardiovascular events like stroke, heart attack, or death for adults with type 2 diabetes with heart disease.

Ozempic works by helping the pancreas make more insulin, decreasing the amount of sugar your liver makes, and slowing the rate food passes through your body, making you feel full longer. This helps to lower blood sugar levels and lowers the risk of a major cardiovascular event.